Talecris has issued a recall for HyperRHO™ S/D, Rh0 (D) Immune Globulin (Human) (Mini-Dose) lot number 26N7XX1.
Talecris distributed the recalled lot only to customers in the United States.
Please find the details regarding this recall within the attached document below.
Recall Notice: HyperRHO™ S/D Mini-Dose
Talecris is aware that the HyperRAB™ S/D, Rabies Immune Globulin (Human) 2 mL prefilled syringe and the GamaSTAN™ S/D, Immune Globulin (Human) 2 mL prefilled syringe do not address all dosing situations.
Please refer to HyperRAB S/D Important Dosing and Administration Information (PDF)
Please refer to GamaSTAN S/D Important Dosing and Administration Information (PDF)
For immediate assistance or questions regarding the dosage and administration of HyperRAB™ S/D or GamaSTAN™ S/D, please call 919.412.1030.
HyperRab™ S/D and GamaSTAN™ S/D 2 mL prefilled syringes have been distributed only in the United States.
Hypermunes™ products for hyperimmune globulin therapy are concentrated immunoglobulins used to treat patients whose immune systems have been compromised. Constant monitoring in steps of the manufacturing and delivery processes makes these biological products safe, easy, and convenient to use.
Vaccines often take weeks to confer full protection, creating a gap of immune vulnerability that may be life threatening. |
Optimize immune protection and close the gap by administering both and immunoglobulin and a vaccine. |
The products discussed herein may only be dispensed with a prescription from a doctor or healthcare provider.
To optimize protection, the greatest benefit comes from combining both active and passive immunization. Hypermunes™ products (Talecris Biotherapeutics hyperimmune globulin products) provide rapid passive immunity in the post-exposure period. When appropriate, concomitant vaccination will initiate an active immune response. Together, these therapies provide optimum immune protection.
Hyperimmune globulin therapy (passive immunization) offers rapid immune protection after exposure. Hyperimmune globulins contain high titers of specific antibodies and are available for prophylaxis against:
| |
Hepatitis A — GamaSTAN™ S/D, Immune Globulin (Human). The use of GamaSTAN™ S/D for post-exposure prophylaxis to hepatitis A is recommended.
|
| |
Hepatitis B — HyperHEP B™ S/D, Hepatitis B Immune Globulin (Human)
|
| |
Rabies — HyperRAB™ S/D, Rabies Immune Globulin (Human)
|
| |
Rh sensitization — HyperRHO™ S/D, Rh0(D), Immune Globulin (Human)
Talecris has issued a recall for HyperRHO™ S/D, Rh0(D) Immune Globulin (Human) (Mini-Dose) lot number 26N7XX1.
Talecris distributed the recalled lot only to customers in the United States.
Please find the details regarding this recall within the attached document below.
Recall Notice: HyperRHO™ S/D Mini-Dose
|
| |
Tetanus — HyperTET™ S/D, Tetanus Immune Globulin (Human) |
The hyperimmunes may be used as prophylaxis in combination with a specific vaccine, when appropriate.
|
